Previous, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases
dc.contributor.authorid | 0000-0002-2730-7307 | |
dc.contributor.authorid | 0000-0002-1171-6819 | |
dc.contributor.authorid | N/A | |
dc.contributor.authorid | 0000-0001-5603-0004 | |
dc.contributor.authorid | 0000-0001-6582-7031 | |
dc.contributor.authorid | 0000-0002-0933-6198 | |
dc.contributor.authorid | 0000-0003-4618-0273 | |
dc.contributor.authorid | 0000-0002-6141-9038 | |
dc.contributor.coauthor | Tezelman, Serdar | |
dc.contributor.coauthor | Terzioglu, Tarik | |
dc.contributor.coauthor | Colakoglu, Bulen Demirkol, Mehmet Onur | |
dc.contributor.coauthor | Kapran, Yersu | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Sezer, Havva | |
dc.contributor.kuauthor | Canbaz, Hande Bulut | |
dc.contributor.kuauthor | Çilingiroğlu Eda Nur | |
dc.contributor.kuauthor | Dereli, Dilek Yazıcı | |
dc.contributor.kuauthor | Deyneli, Oğuzhan | |
dc.contributor.kuauthor | Batman, Adnan | |
dc.contributor.kuauthor | Özışık, Seçil | |
dc.contributor.kuauthor | Alagöl, Faruk | |
dc.contributor.kuprofile | Teaching Faculty | |
dc.contributor.kuprofile | Master Student | |
dc.contributor.kuprofile | Nurse | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Doctor | |
dc.contributor.kuprofile | Doctor | |
dc.contributor.kuprofile | Doctor | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | Graduate School of Health Sciences | |
dc.contributor.schoolcollegeinstitute | N/A | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | N/A | |
dc.contributor.schoolcollegeinstitute | N/A | |
dc.contributor.schoolcollegeinstitute | N/A | |
dc.contributor.unit | Koç University Hospital | |
dc.contributor.yokid | 154807 | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | 179659 | |
dc.contributor.yokid | 171914 | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.date.accessioned | 2025-01-19T10:32:02Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Introduction: Our aims were to explore the relationship between primary hyperparathyroidism (pHPT) and malignant tumour develop- ment, to determine the frequency and the time of occurrence of malignant tumours in patients with pHPT, and to evaluate the charac- teristics of pHPT in these patients. Material and methods: This retrospective cohort study included consecutive individuals who were diagnosed with pHPT aged 18 years or older in a university hospital during a 7-year period. A total of 198 patients with pHPT were reviewed retrospectively. Demographic, clinical, biochemical, radiologic findings, and histopathological diagnosis were collected from the electronic medical records of the hospital system. Results: The mean age of the study population was 58 13 years and was predominantly female (female/male: 162/36). There were 42 (21.2%) patients with malignant tumours. Five (12%) out of 42 patients had metachronous double malignancies. The most common 2 concurrent malignancies were breast (36.1%) and thyroid (17.0%). Sixty-eight per cent of the malignant tumours occurred before the di- agnosis of pHPT. A higher percentage (87.5%) of simultaneous tumours was seen in the thyroid gland. No statistically significant differ- ences were observed between patients with and without malignant tumours in terms of demographic, clinical, biochemical, radiological, and histopathological features. The median follow-up duration was 24 months after parathyroid surgery. Conclusion: The results of this study revealed that pHPT was associated with various tumour types. The frequency of malignant tumours was 21.2%. Breast and thyroid cancers were the most common 2 cancers coexisting with pHPT. A large percentage of malignant tumours occurred before the diagnosis of pHPT. A higher percentage of simultaneous tumours was seen in the thyroid gland. pHPT patients with and without malignant tumours seemed to have similar characteristics. | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 4 | |
dc.description.openaccess | gold | |
dc.description.publisherscope | International | |
dc.description.volume | 74 | |
dc.identifier.doi | 10.5603/EP.a2023.0055 | |
dc.identifier.issn | 0423-104X | |
dc.identifier.quartile | Q3 | |
dc.identifier.scopus | 2-s2.0-85176587976 | |
dc.identifier.uri | https://doi.org/10.5603/EP.a2023.0055 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/26349 | |
dc.identifier.wos | 1118653900001 | |
dc.keywords | Malignant tumour | |
dc.keywords | Hypercalcaemia | |
dc.keywords | Primary hyperparathyroidism | |
dc.keywords | Endocrinology | |
dc.keywords | Metabolism | |
dc.language | en | |
dc.publisher | Via Medica | |
dc.source | Endokrynologia Polska | |
dc.subject | Medicine | |
dc.title | Previous, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases | |
dc.type | Journal Article |
Files
Original bundle
1 - 1 of 1